Diblock copolymer nanoparticles for drug delivery

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 15, Issue 5, 1998, Pages 481-512

  Kwon, Glen S ^a   Kopeček, Jindřich ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Diblock copolymers; Drug delivery; Micelles; Nanoparticles; Nanospheres

Indexed keywords

ANTIGEN; ANTINEOPLASTIC AGENT; COPOLYMER; CYANOACRYLATE DERIVATIVE; DRUG CARRIER; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MACROGOL; NANOPARTICLE; POLOXAMER; POLYGLACTIN; POLYLACTIC ACID;

DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; HUMAN; HYDROPHOBICITY; MICELLE; MOLECULAR RECOGNITION; NONHUMAN; REVIEW; SOLUBILIZATION; SUSTAINED DRUG RELEASE; SYNTHESIS;

EID: 0031761860     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevtherdrugcarriersyst.v15.i5.20     Document Type: Review

References (93)

1. Birrenbach, G. and Speiser, P. P., Polymerized micelles and their use as adjuvants in immunology. J. Pharm. Sci., 65, 1763, 1976.
2. Couvreur, P., Roland, M., and Speiser, P., United States Patent 4, 329, 332, 1982.
3. Douglas, S.J., Davis, S. S., and Illum L., Nanoparticles in drug delivery, CRC Crit. Rev. Ther. Drug Carrier Syst., 3, 235, 1987.
4. Couvreur, P., Polyalkylcyanoacrylates as colloidal drug carriers, CRC Crit. Rev. Ther. Drug Carrier Syst., 5, 1, 1988.
5. Kreuter, J., Peroral administration of nanoparticles, Adv. Drug Deliv. Rev., 7, 71, 1991.
6. Kreuter, J., Berg, U., Liehl, E., Solivia, M., and Speiser, P. P., Influence of the particle size on the adjuvant effect of particulate polymeric adjuvants, Vaccine, 4, 125, 1986.
7. Damge, C., Michel, C., Aprahamian, M., and Couvreur, P., New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier, Diabetes, 37, 26, 1988.
8. Nakada, Y., Fattal, E., Foulquier, M., and Couvreur, P., Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous injection in mice, Pharm. Res., 13, 38, 1996.
9. Cho, M. J. and Juliano, R., Macromolecular versus small-molecule therapeutics: Drug discovery, development and clinical considerations, TIBTECH, 14, 153, 1996.
10. Illum, L. and Davis, S. S., The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (poloxamer 338), FEBS, 167, 79, 1984.
11. Leroux, J, Allemann, E., Jaeghere, F., Doelker E., and Gurny, R., Biodegradable nanoparticles - from sustained release formulations to improved site specific drug delivery, J. Controlled Rel., 39, 339, 1996.
12. Moghimi, S. M., Hawley, A. E., Christy, N. M., Gray, T., Illum, L., and Davis, S. S., Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes, FEBS, 344, 25, 1994.
13. Tomlinson, E., Passive and active vectoring with microparticles: Localization and drug release, J. Controlled Rel., 2, 385, 1985.
14. Cammas, S. and Kataoka, K., Site-specific drug-carriers: Polymeric micelles as high potential vehicles for biologically active molecules, in Solvents and Self-organization of Polymers, Webber, S. E., Munk, P., and Tuzar, Z., Eds., Amsterdam: Kluwer Academic Publishers, 1996, 83.
15. Firestone, R. A., Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells, Bioconj. Chem., 5, 105, 1994.
16. Shaw, J. M. and Schook, L. B., United States Patent 5, 084, 441, 1992.
17. Tahara, H. and Lotze, M. T., Antitumor effects of interleukin-12 (il-12): Applications for the immunotherapy and gene therapy of cancer, Gene Ther., 2, 96, 1995.
18. Koyama. Y., Ishikawa, M., Ueda, A., Sudo, T., Kojima, S., and Suginaka, A., Body distribution of galactose-containing synthetic polymer and galactosylated albumin, Polymer J., 25, 355, 1993.
19. Kossovsky, N., Gelman, A., Sponsler, E., Rajguru, S., Torres, M., Mena, E., Ly, K., and Festekjian, A., Preservation of surface-dependent properties of viral antigens following immobilization on particulate ceramic delivery vehicles, J. Biomed. Mat. Res., 29, 561, 1995.
20. Zhou, F. and Huang, L., Delivery of protein antigen to the major histocompatibility complex class I-restricted antigen presentation pathway, J. Drug Target., 3, 91, 1995.
21. Shearer, G. M. and Clerici, M., Vaccine strategies: Selective elicitation of cellular or humoral immunity, TIBTECH, 15, 106, 1997.
22. Douglas, J. T., Rogers, B. E., Rosenfeld, M. E., Michael, S. I., Feng, M. Z., and Curiel, D. T., Targeted gene delivery by tropism modified adenoviral vectors, Nature-Biotech, 14, 1574, 1996.
23. Kwon, G., Naito, M. Yokoyama, M., Okano, T., Sakurai, Y., and Kataoka, K., Micelles based on ab block copolymers of poly(ethylene oxide) and poly(β-benzyl L-aspartate), Langmuir, 9, 945, 1993.
24. Gref, R., Minamitake. Y., Peracchis, M. T., Trubetskoy, V., Torchilin, V., and Langer, R., Biodegradable long-circulating polymeric nanospheres, Science, 263, 1600, 1994.
25. Choi, Y. K., Bae, Y. G., and Kim, S. W., Block copolymer nanoparticles of ethylene oxide and isobutyl cyanoacrylate, Macromolecules, 28, 8419, 1995.
26. Hagen, S. A., Coombes, G. A., Garnett, M. C., Dunn, S. E., Davies, M. C., Illum, L., and Davis, S. S., polylactide-poly(ethylene glycol) copolymers as drug delivery systems, 1. Characterization of water dispersible micelle-forming systems, Langmuir, 12, 2153, 1996.
27. Wilczek-Vera, G., Danis, P. O., and Eisenberg, A., Individual block length distributions of block copolymers of polystyrene-block-poly(α-methylstyrene) by maldi/tof mass spectroscopy, Macromolecules, 29, 4036, 1996.
28. Gammas, S. and Kataoka, K., Functional poly[(ethylene oxide)-co-(β-benzyl-L-aspartate)] polymeric micelles: Block copolymer synthesis and micelles formation, Macromol. Chem. Phys., 196, 1899, 1995.
29. Daly, W.H. and Poche, D., The preparation of n-carboxyanhydride of α-amino acids using bis(trichloromethyl) carbonate, Tetrahedron Lett., 29, 5859, 1988.
30. Deming, T. J., Facile synthesis of block copolypeptides of defined architecture, Nature, 390, 386, 1997.
31. Zhang, X., Jackson, J. K., and Burt, H. M., Development of amphiphilic diblock copolymers as micellar carriers of taxol, Int. J. Pharm., 132, 195, 1996.
32. Scholz, D., Iijima, M., Nagasaki, Y., and Kataoka, K., A novel reactive polymeric micelle with aldehyde groups on its surfaces, Macromolecules, 28, 7295, 1995.
33. Piskin, E., Kaitian, X., Denkbas, E. B., and Kucukyavuz, Z., Novel pdlla/peg copolymer micelles as drug carriers, J. Biomater. Sci. Polymer Edn., 7, 359, 1995.
34. Cammas, S., Suzuki, K., Sone, C., Sakurai, Y., Kataoka, K., and Okano, T., Thermoresponsive polymer nanoparticles with a core/shell structure as site-speific drug carriers, J. Controlled Rel., 48, 157, 1997.
35. Xu, R., Winnik, M. A., Hallet, F. R., Riess, C., and Croucher, M. D., Light-scattering study of the association behavior of styrene-ethylene oxide block copolymers in aqueous solution, Macromolecules, 24, 87, 1991.
36. Khan, T. N., Mobbs, R. H., Price, C., Quintana, J. R., and Stubbersfield, R. B., Synthesis and colloidal behavior of a polystyrene-b-poly(ethylene oxide) block copolymer, Eur. Polym. J., 23, 191, 1987.
37. Tian, M., Qin, A., Ramireddy, C., Webber, S. E., Munk, P., Tuzar, Z., and Prochazka, K., Hybridization of block copolymer micelles, Langmuir, 9, 1741, 1993.
38. Rolland, A., O'Mullane, J., Goddard, P., Brookman, L., and Petrak, K., New macromolecular carriers for drugs, I. preparation and characterization of poly(oxyethylene-b-isprene-b-oxyethylene) block copolymer aggregates, J. Appl. Polym. Sci, 44, 1195, 1992.
39. Sahli, H., Tapon-Bretaudiere, J., Fischer, A., Sternberg, C., Spenlehauer, G., Verrecchia, T., and Labarre, D., Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with plasma factors of the coagulation system, Biomaterials, 18, 281, 1997.
40. Yokoyama, M., Okano, T., Sakurai, Y., and Kataoka, K., Improved synthesis of adriamycin-conjugated poly(ethylene oxide)-poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin, J. Controlled Rel., 32, 269, 1994.
41. Gao, Z., Varshney, S. K., Wong, S., and Eisenberg, A., Block copolymer "crew cut" micelles in water, Macromolecules, 27, 7923, 1994.
42. Zhang, L. and Eisenberg, A., Multiple morphologies of "crew cut" aggregates of polystyrene-b-poly(acrylic acid) block copolymers, Science, 268, 1728, 1995.
43. Harada, A. and Kataoka, K., Formation of polyion complex micelles in an aqueous milieu from a pair of oppositely-charged block copolymers with poly(ethylene glycol) segments, Macromolecules, 28, 5294, 1995.
44. Kataoka, K., Togawa, H., Harada, A., Yasugi, K., Matsumoto, T., and Katayose, S., Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonucleotide and cationic block copolymer in physiological saline, Macromolecules, 29, 8556, 1996.
45. Katayose, S. and Kataoka, K., PEG-poly(lysine) block copolymer as a novel type of synthetic gene vector with supramolecular structure, in Advanced Biomaterials on Biomedical Engineering and Drug Delivery Systems, Ogata, N., Kim, S. W., Feijen, J., and Okano, T., Eds., Tokyo: Springer, 1996, 319.
46. Katayose, S. and Kataoka, K., Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(l-lysine) block copolymer, Bioconj. Chem., 8, 702, 1997.
47. Wolfert, M. A., Schacht, E. H.,Toncheva, V., Ulbrich, K., Nazarova, O., and Seymour, L. W., Characterization of vectors for gene therapy formed by self-assembly of dna with synthetic block co-polymers, Hum. Gene Ther., 7, 2123, 1996.
48. Kabanov, A. V., Vinogradov, S. V., Suzdaltseva, Y. G., and Alakhov, V. Y., Water-soluble block polycations as carriers for oligonucleotide delivery, Bioconj. Chem., 6, 639, 1995.
49. Oliveira, A. G. and Chaimovich, H., Effect of detergents and other amphiphiles on the stability of pharmaceutical drugs, J. Pharm. Pharmacol, 45, 850, 1992.
50. Milner, S. T., Polymer brushes, Science, 251, 905, 1991.
51. Andrade, J. D., Nagaoka, S., Cooper, S., Okano,T., and Kim S. W., Surfaces and blood compatibility current hypotheses, ASAIO, 10, 75, 1987.
52. Dorn, K., Hoerpel, G., and Ringsdorf, H., Polymeric antitumor agents on a molecular and cellular level, in Bioactive Polymer Systems: An Overview, Gebelein, C. G. and Carraher, Jr., C. E., Eds., New York: Plenum Press, 1985, 531.
53. Edens, M. W., Applications of polyoxyalkylene block copolymer surfactants, in Nonionic Surfactants Polyoxyalkylene Block Copolymers, Nace, V. M., Ed., New York: Marcel Dekker, 1996, 185.
54. Linse, P. and Malmsten, M., Temperature-dependent micellization in aqueous block copolymer solutions, Macromolecules, 25, 5434, 1992.
55. Lowe, K. C., Furmidge, B. A., and Thomas, S., Hæmolytic properties of pluronic surfactants and effects of purification, Artif. Cells Blood Substit. Immobil. Biotechnol., 23, 135, 1995.
56. Quirion, F. and St-Pierre, S., Reduction of the in vitro hemolytic activity of soybean lecithin liposomes by treatment with a block copolymer, Biophys. Chem., 40, 129, 1991.
57. Hunter, R., Strickland, F., and Kezdy, F., The adjuvant activity of nonionic block polymer surfactants, J. Immunol., 127, 1244, 1981.
58. Hunter, R. L. and Bennett, B., The adjuvant activity of nonionic block polymer surfactants, Scand. J. Immunol., 23, 287, 1986.
59. Hunter, R.L., McNicholl, J., and Lal, A. A., Mechanisms of action of nonionic block copolymer adjuvants, AIDS Res. Hum. Retroviruses, 10, S95, 1994.
60. Alakhov, V. Y., Moskaleva, E. Y., Batrakova, E. V., and Kabanov, A. V., Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic p85 block copolymer, Bioconj. Chem., 7, 209, 1996.
61. 6-benzylguanine and its effectiveness against human brain tumor zenografts when given in polyethylene glycol or cremephor-el, Cancer Chemother. Pharmacol., 35, 121, 1994.
62. Kwon, G. S., Naito, M., Yokoyama, M., Okano, T., Sakurai, Y., and Kataoka, K., Physical entrapment of adriamycin in ab block copolymer micelles, Pharm. Res., 12, 192, 1995.
63. Hurter, P. N. and Hatton, T. A., Solubilization of polycyclic aromatic hydrocarbons by poly(ethylene oxide-propylene oxide) block copolymer micelles: Effects of polymer structure, Langmuir, 8, 1291, 1992.
64. Kataoka, K., Kwon, G. S., Yokoyama, M., Okano, T., and Sakurai, Y., Block copolymer micelles as vehicles for drug delivery, J. Controlled Rel., 24, 119, 1993.
65. Yokoyama, M., Okano, T., Sakurai, Y., Suwa, S., and Kataoka, K., Introduction of cisplatin into polymeric micelle, J. Controlled Rel., 39, 351, 1996.
66. Nagarajan, R., Barry, M., and Ruckenstein, E., Unusual selectivity in solubilization by block copolymer micelles, Langmuir, 2, 210, 1986.
67. Gadelle, F., Koros, W. J., and Schechter, R. S., Solubilization of aromatic solutes in block copolymers, Macromolecules, 28, 4883, 1995.
68. Lin, S. and Kawashima, Y., The influence of three poly(oxyethylene) poly-(oxypropylene) surface-active block copolymers on the solubility behavior of indomethacin, Pharm. Acta Helv., 60, 339, 1985.
69. Forster, D., Washington, C., and Davis, S. S., Toxicity of solubilized and colloidal amphotericin b formulations to human erythrocytes, J. Pharm. Pharmacol., 40, 325, 1988.
70. Kabanov, A. V., Chekhonin, V. P., Alakhov, V. Y., Batrakova, E. V., Lebedev, A. S., Melik-Nubarov, N. S., Arzhakov, S. A., Leashov, A. V., Morozov, G. V., Severin, E. S., and Kabanov, V. A., The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles micelles as microcontainers for drug targeting, FEBS, 258, 343, 1989.
71. Lin, S. and Kawashima, Y., Kinetic studies on the stability of indomethacin in alkaline aqueous solutions containing poly(oxyethylene)poly(oxypropylene) surface-active block copolymers, Pharm. Acta Helv., 60, 345, 1985.
72. Yokoyama, M., Kwon, G. S., Okano, T., Sakurai, Y., Seto, T., and Kataoka, K., Preparation of micelle-forming polymer-drug conjugates, Bioconj. Chem., 3, 295, 1992.
73. Kwon, G. S., Naito, M., Kataoka, K., Yokoyama, M., Sakurai, Y., and Okano, T., Block copolymer micelles as vehicles for hydrophobic drugs, Colliods Interfaces B: Biointerfaces, 2, 429, 1994.
74. Yu, B. G., Sardari, S., and Kwon, G. S., Dissociated toxicity, but enhanced antifungal efficacy of amphotericin b loaded poly(ethylene oxide)-block-poly(β benzyl L aspartate) micelles, Pharm. Res., 14, S284, 1997.
75. La, S. B., Okano, T., and Kataoka, K., Preparation and characterization of the micelleforming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(β-benzyl1-aspartate) block copolymer micelles, J. Pharm. Sci., 85, 85, 1996.
76. Cao, T., Munk, P., Ramireddy, C., Tuzar, Z., and Webber, S. E., Fluorescence studies of amphiphilic poly(methacrylic acid)-block-polystyrene-block-poly(methacrylic acid) micelles, Macromolecules, 24, 6300, 1991.
77. Yu, B. G., Okano, T., Kataoka, K., and Kwon, G. S., Polymeric micelles for drug delivery: Solubiliztion and hemolytic activity of amphotericin b, J. Controlled Rel., 33, 131, 1998.
78. Yokoyama, M., Okano, T., Sakurai, Y., Kataoka, K., Shimizu, K., Okamoto, K., Machida, M., and Fukushima, S., Polymeric micelle for anticancer drug delivery, Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 23, 97, 1996.
79. Peracchia, M. T., Gref, R., Minamitake, Y., Domb, A., Lotan, N., and Langer, R., Pegcoated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics, J. Controlled Rel., 46, 223, 1997.
80. Kwon, G. S., Naito, M., Yokoyama, M., Okano, T., Sakurai, Y., and Kataoka, K., Block copolymer micelles for drug delivery: Loading and release of doxorubicin, J. Controlled Rel., 48, 195, 1997.
81. Yokoyama, M., Okano, T., Sakurai, Y., Ekimoto, H., Skibazaki, C., and Kataoka, K., Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood, Cancer Res., 51, 3229, 1991.
82. Kwon, G. S., Suwa, S., Yokoyama, M., Okano, T., Sakurai, Y., and Kataoka, K., Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates, J. Controlled Rel., 29, 17, 1994.
83. Yokoyama, M., Fukushima, S., Uehara, R., Okamoto, K., Kataoka, K., Sakurai, Y., and Okano, T., Characterization of physical entrapment and chemical conjugation of adri amycin in polymeric micelles and their design for in vivo delivery to a solid tumor, J. Controlled Rel., 50, 79, 1998.
84. Miller, D. W., Batrakova, E. V., Waltner, T. O., Alakhov, V. Y., and Kabanov, A. V., Interactions of pluronic block copolymers with brain microvessel endothelial cells: Evidence of two potential pathways for drug absorption, Bioconj. Chem., 8, 649, 1997
85. Kwon, G. S., Yokoyama, M., Okano, T., Sakurai, Y., and Kataoka, K., Biodistribution of micelle-forming polymer-drug conjugates, Pharm. Res., 10, 970, 1993.
86. Maeda, H., Seymour, L. W., and Miyamoto, Y., Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo, Bioconj. Chem., 3, 351, 1992.
87. Batrakova, E. V., Dorodnych, T. Y., Klinskii, E. Y., Kliushnenkova, E. N., Shemchukova, O. B., Goncharova, O. N., Arjakov, S. A., Alakhov, V. Y., and Kabanov, A. V., Anthracyline antiobiotics non-covalendy incorporated into the block copolymer micelles - in vivo evaluation of anti-cancer activity, British J. Cancer, 74, 1545, 1996.
88. Brajtburg, J. and Bolard, J., Carrier effects on biological activity of amphotericin b, Clin. Microbiol. Rev., 9, 512, 1996.
89. Ahmad, I., Longnecker, M., Samuel, J., and Allen, T. A., Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice, Cancer Res., 53, 1484, 1993.
90. Yuan, F., Leunig, M., Uuang, S. K., Berk, D. A., Papahadjopoulos, D., and Jain R. K., Microbascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft, Cancer Res., 54, 3352, 1994.
91. Vandorpe, J., Schacht, E., Dunn, S., Hawley, A., Stolnik, S., Davis, S. S., Garnett, M. C., Davies, M. C., and Illum, L., Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer, Biomaterials, 18, 1147, 1997.
92. Jeong, B., Bae, Y. H., Lee, D. S., and Kim, S. W., Biodegradable block copolymers as injectable drug-delivery systems, Nature, 388, 860, 1997.
93. Trubetskoy, V. S., Gazelle, G. S., Wolf, G. L., and Torchillin, V. P, Block-copolymer of polyethylene glycol and polylysine as a carrier of organic iodine: Design of long-ciculating particulate contrast medium for X-ray computed tomography, J. Drug Targeting, 4, 381, 1997.